| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
29,646
|
27,838
|
26,380
|
25,840
| | Cost of Revenue | 12,520 | 11,112 | 10,804 | 10,167 | | |
Gross Profit
|
17,126
|
16,726
|
15,576
|
15,673
| |
|
Operating Expenses |
|
Research Development | 2,606 | 2,282 | 2,277 | 2,182 |
|
Selling General and Administrative | 9,471 | 9,216 | 7,895 | 7,878 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 1,876 | 1,882 | 1,673 | 1,572 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
3,173
|
3,346
|
3,731
|
4,041
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 47 | 31 | 42 | 26 |
|
Earnings Before Interest And Taxes | 3,220 | 3,377 | 3,773 | 4,067 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 3,220 | 3,377 | 3,773 | 4,067 |
|
Income Tax Expense | 1,279 | 1,556 | 1,796 | 1,640 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,941 | 1,821 | 1,977 | 2,427 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,941
|
1,821
|
1,977
|
2,427
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,941
|
1,821
|
1,977
|
2,427
|
|
0.28(1.11%) 11:01AM EDT - Nasdaq Real Time Price